MPW

$3.86

▲+2.66%

wb_incandescent Backtest

Stock

Medical Properties Trust Inc. common stock

Official Company Name: Medical Properties Trust, Inc.

Stock Symbol: MPW

Stock Market: New York Stock Exchange - NYSE

Currency: United States dollar - USD

business Medical Properties Trust, Inc. Company Profile

MPW - Stock Indices

MPW Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▼-21.22%

file_download

Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Medical Properties Trust, Inc. is a real estate investment trust specialized in net lease medical properties. Operating a number of hospitals and medical facilities, Medical Properties Trust owns medical properties in the United States, Germany, the United Kingdom, Switzerland, Australia, Italy, Spain, Colombia, and Portugal.

business Medical Properties Trust, Inc. Company Profile

MPW Stock Data

Open $3.73
High $3.89
Low $3.72
Close $3.86
Volume 22,914,900
Previous Close $3.76
1-Day Change 0.10
1-Year Change -1.04
Average Daily Volume 16,331,779
52-Week High $6.37
52-Week Low $3.07

MPW Stock References

warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.